Clinical Trials Browser

Phase 3 × Hematologic Neoplasms × Vincristine × Clear all

NCT00215943 2014-04-17

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Phase 3 Terminated

90 enrolled 10 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms